BlackRock, Inc. (BLK) 13D/13G Filings for Lyell Immunopharma, Inc. (LYEL)

BlackRock, Inc. 13D and 13G filings for Lyell Immunopharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-02-05
1:23 pm
Sale
2024-12-3113GLyell Immunopharma, Inc.
LYEL
BlackRock Inc.
BLK
663,293
4.500%
-51,818decrease
(-7.25%)
Filing
2024-01-29
5:25 pm
Purchase
2023-12-3113GLyell Immunopharma, Inc.
LYEL
BlackRock Inc.
BLK
715,111
5.700%
715,111increase
(New Position)
Filing